Morgan Stanley Has $5.55 Million Holdings in Tabula Rasa HealthCare Inc (NASDAQ:TRHC)

Morgan Stanley raised its stake in Tabula Rasa HealthCare Inc (NASDAQ:TRHC) by 68.7% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 111,164 shares of the company’s stock after acquiring an additional 45,271 shares during the quarter. Morgan Stanley’s holdings in Tabula Rasa HealthCare were worth $5,550,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Morgens Waterfall Vintiadis & Co. Inc. increased its position in Tabula Rasa HealthCare by 25.0% in the 2nd quarter. Morgens Waterfall Vintiadis & Co. Inc. now owns 20,000 shares of the company’s stock valued at $999,000 after acquiring an additional 4,000 shares in the last quarter. Bank of America Corp DE increased its position in Tabula Rasa HealthCare by 14.3% in the 2nd quarter. Bank of America Corp DE now owns 620,683 shares of the company’s stock valued at $30,991,000 after acquiring an additional 77,578 shares in the last quarter. Venator Capital Management Ltd. increased its position in Tabula Rasa HealthCare by 36.5% in the 2nd quarter. Venator Capital Management Ltd. now owns 109,900 shares of the company’s stock valued at $5,487,000 after acquiring an additional 29,376 shares in the last quarter. Quadrant Private Wealth Management LLC increased its position in Tabula Rasa HealthCare by 3.2% in the 2nd quarter. Quadrant Private Wealth Management LLC now owns 31,995 shares of the company’s stock valued at $1,598,000 after acquiring an additional 1,000 shares in the last quarter. Finally, BlackRock Inc. increased its position in Tabula Rasa HealthCare by 4.0% in the 2nd quarter. BlackRock Inc. now owns 2,752,675 shares of the company’s stock valued at $137,441,000 after acquiring an additional 105,190 shares in the last quarter. Hedge funds and other institutional investors own 98.87% of the company’s stock.

In related news, CFO Brian W. Adams sold 10,000 shares of Tabula Rasa HealthCare stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $60.00, for a total transaction of $600,000.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, President Orsula V. Knowlton sold 8,000 shares of Tabula Rasa HealthCare stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $56.23, for a total transaction of $449,840.00. The disclosure for this sale can be found here. Insiders have sold a total of 78,000 shares of company stock worth $4,492,530 in the last three months. 11.80% of the stock is owned by insiders.

Several equities research analysts have weighed in on TRHC shares. BidaskClub cut shares of Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a research report on Friday, October 11th. Stifel Nicolaus upgraded shares of Tabula Rasa HealthCare from a “hold” rating to a “buy” rating and lifted their price target for the stock from $50.00 to $75.00 in a research report on Friday, August 30th. Zacks Investment Research cut shares of Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a research report on Thursday, October 10th. ValuEngine upgraded shares of Tabula Rasa HealthCare from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, September 4th. Finally, Piper Jaffray Companies set a $78.00 price target on shares of Tabula Rasa HealthCare and gave the stock a “buy” rating in a research report on Friday, October 18th. Three research analysts have rated the stock with a hold rating, six have given a buy rating and two have issued a strong buy rating to the stock. Tabula Rasa HealthCare presently has a consensus rating of “Buy” and a consensus target price of $78.26.

Shares of NASDAQ:TRHC opened at $49.50 on Wednesday. Tabula Rasa HealthCare Inc has a one year low of $40.86 and a one year high of $81.83. The company has a 50 day moving average of $54.23 and a 200-day moving average of $53.18. The company has a debt-to-equity ratio of 1.31, a current ratio of 1.97 and a quick ratio of 1.90. The stock has a market cap of $1.08 billion, a price-to-earnings ratio of 145.59 and a beta of 1.66.

Tabula Rasa HealthCare (NASDAQ:TRHC) last released its quarterly earnings data on Thursday, August 8th. The company reported $0.35 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.29. Tabula Rasa HealthCare had a negative net margin of 7.09% and a positive return on equity of 3.63%. The business had revenue of $76.26 million for the quarter, compared to analyst estimates of $70.40 million. During the same quarter last year, the firm earned $0.20 EPS. Tabula Rasa HealthCare’s quarterly revenue was up 56.9% compared to the same quarter last year. Equities research analysts anticipate that Tabula Rasa HealthCare Inc will post -0.15 earnings per share for the current year.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems.

Recommended Story: What is Green Investing?

Want to see what other hedge funds are holding TRHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tabula Rasa HealthCare Inc (NASDAQ:TRHC).

Institutional Ownership by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.